Psilocybin therapy reduced depression symptoms in clinicians who developed these symptoms after frontline clinical work during the COVID-19 pandemic, a small randomized trial showed.
At day 28, the mean change in Montgomery-Åsberg Depression Rating Scale (MADRS) score was -21.33 compared with -9.33 for those who received niacin (P
Source : MedPageToday